Howe & Rusling’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Sell |
5,106
-556
| -10% | -$198K | 0.12% | 105 |
|
|
2025
Q4 | $1.85M | Buy |
5,662
+406
| +8% | +$129K | 0.12% | 99 |
|
|
2025
Q3 | $1.48M | Buy |
5,256
+317
| +6% | +$91.9K | 0.1% | 111 |
|
|
2025
Q2 | $1.38M | Sell |
4,939
-107
| -2% | -$30.3K | 0.1% | 110 |
|
|
2025
Q1 | $1.57M | Buy |
5,046
+166
| +3% | +$49K | 0.13% | 103 |
|
|
2024
Q4 | $1.27M | Buy |
4,880
+22
| +0.5% | +$6.53K | 0.11% | 104 |
|
|
2024
Q3 | $1.57M | Buy |
4,858
+151
| +3% | +$49.4K | 0.13% | 103 |
|
|
2024
Q2 | $1.47M | Sell |
4,707
-157
| -3% | -$46.1K | 0.13% | 103 |
|
|
2024
Q1 | $1.38M | Sell |
4,864
-204
| -4% | -$59.7K | 0.13% | 108 |
|
|
2023
Q4 | $1.46M | Buy |
5,068
+16
| +0.3% | +$4.36K | 0.15% | 104 |
|
|
2023
Q3 | $1.36M | Buy |
5,052
+67
| +1% | +$16.7K | 0.16% | 103 |
|
|
2023
Q2 | $1.11M | Buy |
4,985
+35
| +0.7% | +$8.12K | 0.12% | 108 |
|
|
2023
Q1 | $1.2M | Buy |
4,950
+193
| +4% | +$47.4K | 0.14% | 106 |
|
|
2022
Q4 | $1.25M | Sell |
4,757
-566
| -11% | -$152K | 0.16% | 96 |
|
|
2022
Q3 | $1.2M | Sell |
5,323
-40
| -0.7% | -$9.7K | 0.16% | 98 |
|
|
2022
Q2 | $1.3M | Buy |
5,363
+1,654
| +45% | +$405K | 0.17% | 96 |
|
|
2022
Q1 | $897K | Sell |
3,709
-108
| -3% | -$24.8K | 0.1% | 107 |
|
|
2021
Q4 | $859K | Sell |
3,817
-10
| -0.3% | -$2.11K | 0.1% | 107 |
|
|
2021
Q3 | $814K | Sell |
3,827
-97
| -2% | -$22.3K | 0.1% | 106 |
|
|
2021
Q2 | $956K | Sell |
3,924
-50
| -1% | -$12.3K | 0.12% | 96 |
|
|
2021
Q1 | $989K | Sell |
3,974
-102
| -3% | -$24.3K | 0.13% | 90 |
|
|
2020
Q4 | $937K | Buy |
4,076
+162
| +4% | +$37.4K | 0.14% | 86 |
|
|
2020
Q3 | $995K | Buy |
3,914
+80
| +2% | +$19.8K | 0.17% | 77 |
|
|
2020
Q2 | $904K | Sell |
3,834
-316
| -8% | -$72.1K | 0.17% | 71 |
|
|
2020
Q1 | $841K | Sell |
4,150
-35,294
| -89% | -$7.71M | 0.18% | 75 |
|
|
2019
Q4 | $9.51M | Sell |
39,444
-6,215
| -14% | -$1.37M | 1.57% | 19 |
|
|
2019
Q3 | $8.84M | Sell |
45,659
-968
| -2% | -$186K | 1.55% | 16 |
|
|
2019
Q2 | $8.59M | Buy |
46,627
+973
| +2% | +$174K | 1.48% | 21 |
|
|
2019
Q1 | $8.67M | Buy |
45,654
+1,510
| +3% | +$288K | 1.5% | 23 |
|
|
2018
Q4 | $8.59M | Buy |
44,144
+41,121
| +1,360% | +$8.02M | 1.82% | 16 |
|
|
2018
Q3 | $627K | Buy |
3,023
+208
| +7% | +$41K | 0.1% | 95 |
|
|
2018
Q2 | $520K | Sell |
2,815
-55
| -2% | -$9.73K | 0.09% | 97 |
|
|
2018
Q1 | $489K | Sell |
2,870
-1,029
| -26% | -$189K | 0.09% | 110 |
|
|
2017
Q4 | $678K | Sell |
3,899
-35
| -0.9% | -$6.19K | 0.12% | 100 |
|
|
2017
Q3 | $734K | Buy |
3,934
+1,063
| +37% | +$188K | 0.14% | 93 |
|
|
2017
Q2 | $494K | Sell |
2,871
-85
| -3% | -$13.8K | 0.1% | 103 |
|
|
2017
Q1 | $485K | Buy |
2,956
+31
| +1% | +$5.15K | 0.1% | 101 |
|
|
2016
Q4 | $428K | Buy |
2,925
+55
| +2% | +$8.28K | 0.09% | 108 |
|
|
2016
Q3 | $479K | Hold |
2,870
| – | – | 0.1% | 97 |
|
|
2016
Q2 | $437K | Sell |
2,870
-50
| -2% | -$7.77K | 0.1% | 103 |
|
|
2016
Q1 | $438K | Hold |
2,920
| – | – | 0.1% | 107 |
|
|
2015
Q4 | $474K | Buy |
2,920
+32
| +1% | +$5.03K | 0.11% | 102 |
|
|
2015
Q3 | $399K | Sell |
2,888
-270
| -9% | -$42.6K | 0.1% | 110 |
|
|
2015
Q2 | $485K | Sell |
3,158
-1
| -0% | -$160 | 0.11% | 113 |
|
|
2015
Q1 | $505K | Sell |
3,159
-124
| -4% | -$19.5K | 0.11% | 108 |
|
|
2014
Q4 | $523K | Sell |
3,283
-75
| -2% | -$11.7K | 0.13% | 107 |
|
|
2014
Q3 | $472K | Sell |
3,358
-113
| -3% | -$14.8K | 0.11% | 113 |
|
|
2014
Q2 | $402K | Buy |
3,471
+150
| +5% | +$17.4K | 0.09% | 120 |
|
|
2014
Q1 | $410K | Buy |
3,321
+92
| +3% | +$11.2K | 0.1% | 110 |
|
|
2013
Q4 | $368K | Sell |
3,229
-225
| -7% | -$25.6K | 0.09% | 114 |
|
|
2013
Q3 | $391K | Hold |
3,454
| – | – | 0.14% | 98 |
|
|
2013
Q2 | $341K | Buy |
+3,454
| New | +$358K | 0.09% | 126 |
|
Other funds holding AMGN
VCM
VPM
Howe & Rusling's AMGN Position: Q1 2026 in Review
Howe & Rusling reduced its Amgen (AMGN) stake by 9.8% in Q1 2026, selling an estimated $198K and leaving 5,106 shares worth $1.8M. The position accounts for 0.12% of the portfolio, ranked #105.
Howe & Rusling first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.51M in Q4 2019. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Howe & Rusling held 5,106 shares of Amgen worth $1.8M as of Q1 2026.
- Howe & Rusling sold 556 Amgen shares in Q1 2026, an estimated $198K.
- Amgen made up 0.12% of Howe & Rusling's portfolio in Q1 2026, its #105 holding.
- Howe & Rusling first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Howe & Rusling's Amgen position peaked at $9.51M in Q4 2019.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.